Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)

Back

ESC Premium Access

Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)

Session: Congress committee e-posters choice in CAD/ACS/ACC

Topic: Pharmacotherapy

Speaker: Doctor B. Mengesha (Ottawa, CA)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Bethlehem Mengesha

University of Ottawa Heart Institute, Ottawa (Canada)

0 follower

28 more presentations in this session

Post-discharge major bleeding, myocardial infarction and mortality risk after coronary artery bypass grafting: A nationwide cohort study from the SWEDEHEART registry

Speaker: Doctor E. Bjoerklund (Gothenburg, SE)

Access

Abstract

Slides

Trends in cardiovascular mortality of cancer patients in the US over two decades 1999-2019

Speaker: Doctor O. Kobo (Hadera, IL)

Access

Abstract

Slides

Underuse of reperfusiontherapy in STEMI with cardiogenic shock. Results of the EORP ACVC EAPCI STEMI registry of the ESC.

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Access

Abstract

Slides

The effect of immediate coronary angiography after cardiac arrest without ST-segment elevation on left ventricular function. A sub-study of the COACT randomised trial

Speaker: Doctor J. Lemkes (Amsterdam, NL)

Access

Abstract

Slides

Comparison of risk prediction models in infarct-related cardiogenic shock

Speaker: Doctor A. Freund (Leipzig, DE)

Access

Abstract

Slides

Access the full session

Congress committee e-posters choice in CAD/ACS/ACC

Speakers: Doctor B. Mengesha, Doctor E. Bjoerklund, Doctor O. Kobo, Professor U. Zeymer, Doctor J. Lemkes...

Access

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources